Moreover, the results of online analysis with TIMER2.0 suggested a positive correlation between PEAR1 and CD44 expression levels in numerous cancers, such as blood, brain, colorectal, and ovarian cancer (data not shown). Here, CD44 is linked to ovarian carcinoma.